Improved Survival in Europe

Findings from a retrospective observational study that included patients diagnosed with haematological malignancies from 20 European countries showed that survival increased for most haematological malignancies.

The investigators analysed 560,444 cases from 30 cancer registries that had continuous incidence as well as good quality data from 1992 to 2007. The largest increases in survival were seen for diffuse large B-cell lymphoma (42.0% [95% CI 40.7-43.4] to 55.4% [54.6-56.2], p<0.0001) and follicular lymphoma (58.9% [57.3-60.6] to 74.3% [72.9-75.5], p<0.0001). The widespread use of newer and more effective therapies likely accounts for the improvement seen in survival. For more information, click here.


Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe


Have you ever attended a meeting with a lymphoma support group?




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.